These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11411380)

  • 1. Polio eradication and after: does IPV have a role?
    Mathew JL; Mittal SK
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S15-22. PubMed ID: 11411380
    [No Abstract]   [Full Text] [Related]  

  • 2. Will India need inactivated poliovirus vaccine (IPV) to complete polio eradication?
    John TJ
    Indian J Med Res; 2005 Nov; 122(5):365-7. PubMed ID: 16456246
    [No Abstract]   [Full Text] [Related]  

  • 3. Polio eradication in India: how far are we from reaching the goal?
    Banerjee K; Sahu S; Bandyopadhyay S
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S6-14. PubMed ID: 11411387
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral polio vaccines and their role in polio eradication in India.
    Paul Y
    Expert Rev Vaccines; 2009 Jan; 8(1):35-41. PubMed ID: 19093771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What needs to be done for polio eradication in India?
    Paul Y
    Vaccine; 2007 Aug; 25(35):6431-6. PubMed ID: 17646037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPV cannot eradicate polio from India: do we need any further evidence?
    Paul Y
    Vaccine; 2008 Apr; 26(17):2058-61. PubMed ID: 18378367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program.
    Shahzad A; Köhler G
    Vaccine; 2009 Aug; 27(39):5293-4. PubMed ID: 19638271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of polio by vaccination.
    Minor PD
    Virology; 2000 Mar; 268(2):231-2. PubMed ID: 10704330
    [No Abstract]   [Full Text] [Related]  

  • 14. Global health. Polio eradication: is it time to give up?
    Roberts L
    Science; 2006 May; 312(5775):832-5. PubMed ID: 16690830
    [No Abstract]   [Full Text] [Related]  

  • 15. Polio eradication. Looking for a little luck.
    Roberts L
    Science; 2009 Feb; 323(5915):702-5. PubMed ID: 19197035
    [No Abstract]   [Full Text] [Related]  

  • 16. Killed polio virus vaccine in the control of poliomyelitis in Finland.
    Lapinleimu K
    Ann Clin Res; 1982 Dec; 14(5-6):199-203. PubMed ID: 6303196
    [No Abstract]   [Full Text] [Related]  

  • 17. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC; Dutta A
    Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.